Zhitong Finance App News, Hewang Pharmaceutical (00013.HK) announced that it will jointly hold an online expert interpretation session for analysts and investors with Citibank Global Finance Asia Limited (Citibank for short) to discuss the latest phase III clinical data of savotinib for the treatment of MET-driven non-small cell lung cancer, which was recently announced at the 2026 European Society of Medical Oncology (ESMO) annual meeting. The online conference will be held on November 5, 2026 (Thursday) at 4:30 p.m. Hong Kong Time/8:30 a.m. GMT/3:30 a.m. EST.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.